NGS Clinical Assays

Unlock deeper genomic insights with precision-engineered sequencing panels that enable comprehensive genetic profiling. Designed to deliver accurate detection of clinically relevant variants, these solutions support advanced diagnostics, hereditary screening, oncology applications, and personalized medicine.

Point Of care Testing Solutions

Rapid, portable, and easy-to-use molecular testing systems that deliver lab-grade accuracy anywhere. Ideal for decentralized testing environments, clinics, screening centers, and on-site diagnostics where speed, accessibility, and accuracy are critical.

RT-PCR Kits

Flexible and scalable RT-PCR platforms that work with a wide range of reagents, assays, and workflows. Designed for clinical laboratories and research settings, these systems enable high-throughput, cost-effective molecular testing with complete operational freedom.

Nucleic Acid Extraction Solutions

High-efficiency extraction kits and automated systems that ensure pure, consistent, and reliable recovery of DNA and RNA. Built for seamless workflow integration, they provide the ideal foundation for downstream molecular applications including PCR, sequencing, and clinical testing.

DISCOVER OUR PRODUCTS

Explore our innovative, cutting-edge solutions in molecular diagnostics.

Related News, Media & Blogs

G2M Press Release

Revolutionizing sepsis diagnosis: assessing the Genes2Me ’Sepsis-Q’ Point-of-Care Test for rapid detection of 32 sepsis pathogens from whole blood in just 90 minutes.

“37th European Congress of Pathology - Abstracts”

PCR Testing Kit

Advanced technology for efficient tuberculosis, NTM, and drug resistance detection using Genes2Me OnePCR and Rapi-Q

37th European Congress of Pathology - Abstracts

READ ARTICLE
Real Time PCR System

STI Detection: Ensuring Early Diagnosis for Better Health Outcomes

Sexually transmitted infections (STIs) are a significant global health concern, affecting millions of people each year.

READ Blogs
PCR Testing System

Actionable mutational landscape in solid tumors: a case study of ovarian and colon cancer.

Abstract 1903: Actionable mutational landscape in solid tumors: a case study of ovarian and colon cancer

READ ARTICLE

Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.

All products listed in the catalogue are the products of Genes2Me Private Limited. Apart from that, all other product names, trademarks and logos wherever used in the catalogue are the property of their respective owners.


© 2025 Genes2me. All rights reserved.